Nitric Oxide News and Research

RSS

NIOX® launches NIOX PRO®, their next generation FeNO testing device

NIOX Group plc, a global leader in fractional exhaled nitric oxide (FeNO) testing, has announced the launch of NIOX PRO®, its next-generation FeNO testing device designed to support healthcare professionals in the diagnosis and management of asthma, COPD and other inflammatory airway diseases.

From NIOX Group PLC 28 Oct 2026

Low vitamin B12 is linked to heart disease. Supplements tell a different story

A narrative review published in Nutrition Journal examines how vitamin B12 deficiency may contribute to cardiovascular disease through elevated homocysteine, endothelial dysfunction, oxidative stress and altered methylation. The authors found that B12 supplementation has not consistently prevented heart attacks or cardiovascular deaths in clinical trials, although combined B-vitamin therapy may modestly reduce stroke risk, particularly in populations without folic acid fortification.

27 Oct 2026

Biological framework tracks postpartum vulvar tissue recovery timelines

A new biological model published in Sexual Medicine Reviews by Oxford University Press addresses why pain with sex after childbirth-reported by 60% of women at three months-persists for some long after hormones return to normal.

21 Oct 2026

Why the same healthy diet may not work the same way for everyone

A review published in Nutrients proposes a seven-pillar precision nutrition framework that combines biological, behavioral, and environmental information to tailor dietary interventions throughout life. The authors identify potential benefits for cardiovascular, respiratory, blood, and sleep health, while emphasizing the need for further clinical trials to establish effective, accessible, and personalized nutritional strategies.

20 Oct 2026

Bedfont® Scientific Ltd. acquires US-based company coVita™, marking the next chapter in its global growth

Bedfont®, a world leader in breath analysis, announces its acquisition of coVita™, building on 16 years of partnership, market knowledge, and established infrastructure to support global expansion.

From Bedfont® Scientific Ltd 13 Oct 2026

Why one gut microbe is attracting attention in heart failure research

Researchers found that chronic systolic heart failure caused by nonischemic cardiomyopathy was associated with reduced gut microbial diversity, depletion of Bifidobacterium, and lower microbial short-chain fatty acid production potential. Higher Bifidobacterium abundance and higher circulating indole-3-propionic acid levels were associated with milder disease and clinical improvement, although the findings do not establish causality.

27 Sep 2026

Beetroot juice may make swimming feel easier without making swimmers faster

A systematic review and meta-analysis of 12 studies, with nine contributing data from 120 swimmers, found no significant improvement in swimming time-trial performance or post-exercise blood lactate with beetroot juice or dietary nitrate supplementation. Supplementation produced a small reduction in perceived exertion, but the effect varied across studies, and the certainty of evidence for swimming performance was low.

24 Sep 2026

Salt-purified seaweed compound suppresses inflammatory and allergic reactions

Food allergies affect an estimated 3%–4% of the global population, yet no definitive cure is currently available.

22 Sep 2026

Bedfont® Scientific one step closer to improving smoking cessation in Latin America

Bedfont® Scientific Limited, an innovative MedTech company with nearly 50 years of experience in the breath analysis industry, is pleased to collaborate with Medicah S.A.S through a new registration for the Smokerlyzer® range of carbon monoxide (CO) monitoring devices.

From Bedfont® Scientific Ltd 9 Sep 2026

Scientists develop lab-grown heart tissue model for heart failure

Scientists study the underlying causes of a disease or test new potential drugs in animal models or cells obtained from human biopsy specimens before clinical trials.

2 Sep 2026

Sunlight, blood sugar and diabetes: a new study finds an intriguing connection

Higher short-term ambient UVA exposure was associated with modestly lower blood glucose levels, particularly during winter, in a large UK Biobank analysis. Separately, more frequent solarium use, used as a proxy for habitual sunlight exposure, was associated with a lower hazard of type 2 diabetes, although the observational findings do not establish causality.

27 Aug 2026

New review examines oral cancer drug delivery barriers and strategies

Delivering drugs directly to oral tumor sites remains challenging. A recent review involving researchers from Hasanuddin University examines barriers to local drug delivery and analyses strategies for targeting oral cancer lesions.

26 Aug 2026

What decades of wine research can, and cannot, tell us about health

A narrative review found that moderate wine intake has repeatedly been associated with lower all-cause and cardiovascular mortality, with proposed mechanisms involving ethanol and grape-derived polyphenols, but the evidence remains largely observational and cannot establish causation. The authors argue that drinking pattern, beverage type, age, cancer risk, and risk-modeling choices all influence how the J-shaped association should be interpreted and how alcohol guidelines are developed.

25 Aug 2026

Glioma microenvironment emerges as key target for future therapies

The prognosis for glioma patients remains extremely poor despite aggressive multimodal standard therapy: maximal safe resection, radiotherapy, and temozolomide chemotherapy, with median survival rarely exceeding 15 to 18 months.

20 Aug 2026

Superstorm Sandy reshaped indoor fungal communities, with an unexpected asthma result

and lower fungal diversity than non-damaged homes. Despite these persistent but variable fungal changes, researchers found no statistically significant increase in asthma morbidity, impaired lung function, or airway inflammation among children with relatively mild asthma.

13 Aug 2026

Bedfont® brings respiratory monitoring solutions to ERS with a focus on clinical research

Bedfont® Scientific Limited, a world leader in breath analysis, is excited to be attending this year's European Respiratory Society (ERS) Congress in Barcelona.

From NObreath 12 Aug 2026

First-trimester protein intake linked to lower odds of small-for-gestational-age birth

A secondary analysis of 7,067 nulliparous participants found that first-trimester protein intake of 0.8 to less than 1.1 g/kg/day was associated with 22% lower adjusted odds of delivering an SGA infant than intake of at least 1.1 g/kg/day. The association was exploratory, with no dose-response pattern and no confirmation in sensitivity analyses.

6 Aug 2026

Perilla oil may curb platelet reactivity and inflammatory signaling in smokers

An eight-week randomized trial found that daily perilla oil increased plasma and red-cell ALA, plasma EPA, and platelet closure time in healthy smokers. Perilla oil also reduced TNF-α and TBX21 gene expression, but it did not improve broader coagulation, lipid, endothelial, or postprandial markers.

3 Aug 2026

Hydrogen-powered shipping could deliver $284 billion in annual health benefits

Researchers modeled how replacing conventional global shipping fuels with hydrogen could change PM2.5 and ozone pollution, premature mortality, and monetized health benefits. Under complete transition, the model estimated 129,458 fewer premature deaths and US$284 billion in annual monetized health benefits, although some regions experienced increased pollution from hydrogen production or altered ozone chemistry.

31 Jul 2026

Review finds blueberry and grape polyphenols may improve vascular health

A review of 37 publications found that grape- and blueberry-derived polyphenols were associated with modest improvements in cardiovascular risk markers, particularly endothelial function. However, most studies were small or short-term, frequently tested concentrated products, and measured biomarkers rather than cardiovascular events.

27 Jul 2026